Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.33
-0.05 (-0.68%)
Apr 23, 2026, 12:03 PM EDT - Market open
Wave Life Sciences Employees
Wave Life Sciences had 317 employees as of December 31, 2025. The number of employees increased by 29 or 10.07% compared to the previous year.
Employees
317
Change (1Y)
29
Growth (1Y)
10.07%
Revenue / Employee
$134,785
Profits / Employee
-$644,726
Market Cap
1.41B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 317 | 29 | 10.07% | 317 | 0 |
| Dec 31, 2024 | 288 | 20 | 7.46% | 287 | 1 |
| Dec 31, 2023 | 268 | 16 | 6.35% | 266 | 2 |
| Dec 31, 2022 | 252 | 14 | 5.88% | 250 | 2 |
| Dec 31, 2021 | 238 | 18 | 8.18% | 235 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immatics | 711 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Viridian Therapeutics | 252 |
| Precigen | 160 |
| Olema Pharmaceuticals | 131 |
| AnaptysBio | 104 |
WVE News
- 1 day ago - Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 - GlobeNewsWire
- 1 day ago - Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States - GlobeNewsWire
- 7 days ago - Wave Life Sciences Announces Proposed Redomiciliation to the United States - GlobeNewsWire
- 27 days ago - Wave Life Sciences stock crash: why analyst sees a buying opportunity - Invezz
- 4 weeks ago - Why Is Wave Life Sciences Stock Falling After Weight Loss Study Data? - Benzinga
- 4 weeks ago - WAVE LIFE SCIENCES Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 4 weeks ago - Wave Life Sciences shares plunge as data for high dose of obesity drug disappoints - Reuters
- 4 weeks ago - Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007 - GlobeNewsWire